Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor plus aspirin versus clopidogrel plus aspirin in minor ischemic stroke or high-risk transient ischemic attack
IRCT20200112046094N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in ischemic stroke and transient ischaemic attack (TIA) comparing Ticagrelor plus aspirin with Clopidogrel plus aspirin (2 arms). Primary endpoints: Ischemic stroke recurrence during first 3 months and Major bleeding event. Started Aug 2021; status: completed.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on IRCT20200112046094N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200112046094N2.